We ran mRNA instead of total RNA assays, and are left with rRNA contamination values instead of RINs. The traces of the RNAs all look fine, so it seems that the data are there, and all we need is to find a way to get the RIN from them. Is there a way to (non-manually) obtain RINs after running mRNA assays? I also posted this question as a response to a related thread in this forum, but decided to create a new thread in addition, because it seems like a problem that is not unlikely to occur to people doing library preps. Thanks for any help.
-
-
No, I don't think this is possible. But if you figure out a way, please post it.
--
Phillip -
I recall reading that RIN is the value assigned mainly based on rRNA peaks. So even if you'd get RIN value for your samples it might be wrong because without rRNA peaks the algorithm might misinterpret the RNA integrity. This is how I understood it.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment